Chromocell Therapeutics Corp [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
	S-1/A	S-1/A	S-1
Revenues	0.0	0.0	0.2
Revenue growth		-100.0%
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.2
Gross margin			100.0%
Selling, general and administrative [+]	1.9	0.6	1.4
Sales and marketing	0.8	0.1	0.1
General and administrative	1.1	0.5	1.3
Other selling, general and administrative	0.8	0.1	0.1
Research and development	0.4	0.2	0.1
Other operating expenses			0.7
EBIT [+]	-2.3	-0.8	-2.0
EBIT growth	176.3%	-59.0%
EBIT margin			-1024.8%
Non-recurring items [+]			-0.7
Loss (gain) on sale of assets			-0.7
Interest expense	0.1	0.0	0.0
Interest expense	0.1	0.0	0.0
Other income (expense), net		0.2	0.7
Pre-tax income	-2.5	-0.6	-0.7
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-2.5	-0.6	-0.7
Net margin			-330.4%

Basic EPS	($0.63)
Diluted EPS	($0.63)

Shares outstanding (basic)	3.9
Shares outstanding (diluted)	3.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.